Jigar Raythatha - Sep 13, 2021 Form 4 Insider Report for Jounce Therapeutics, Inc. (JNCE)

Role
Director
Signature
/s/ Elizabeth Shortsleeve, Attorney-in-Fact
Stock symbol
JNCE
Transactions as of
Sep 13, 2021
Transactions value $
$0
Form type
4
Date filed
9/15/2021, 08:16 AM
Previous filing
Jul 19, 2021
Next filing
Jun 28, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction JNCE Common Stock Award $0 +31.4K $0.00 31.4K Sep 13, 2021 Common Stock 31.4K $6.47 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option was granted on September 13, 2021 and will vest in equal quarterly installments during the twelve quarters following the grant date, subject the to Reporting Person's continued service as a director.